These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 21737486

  • 1. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
    Rubio-Guerra AF, Vargas-Robles H, Vargas-Ayala G, Rodríguez-Lopez L, Castro-Serna D, Escalante-Acosta BA.
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
    [Abstract] [Full Text] [Related]

  • 2. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
    Rubio-Guerra AF, Vargas-Robles H, Vargas-Ayala G, Rodriguez-Lopez L, Escalante-Acosta BA.
    Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P, Vaur L, Dutrey-Dupagne C, Genes N, Destrée D, Elkik F.
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [Abstract] [Full Text] [Related]

  • 4. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators.
    N Engl J Med; 2004 Nov 04; 351(19):1941-51. PubMed ID: 15516697
    [Abstract] [Full Text] [Related]

  • 5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G, BENEDICT Study Group.
    J Am Soc Nephrol; 2006 Dec 04; 17(12):3472-81. PubMed ID: 17082240
    [Abstract] [Full Text] [Related]

  • 6. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
    Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriguez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT.
    Diabetes Care; 2004 Jul 04; 27(7):1688-91. PubMed ID: 15220247
    [Abstract] [Full Text] [Related]

  • 7. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb 04; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 8. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J, Dzúrik R.
    Vnitr Lek; 1998 Jun 04; 44(6):326-31. PubMed ID: 9820054
    [Abstract] [Full Text] [Related]

  • 9. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R, Puig JG, Rodríguez-Pérez JC, Garrido J, Redon J, TRAVEND Study Group.
    J Hum Hypertens; 2001 Dec 04; 15(12):849-56. PubMed ID: 11773987
    [Abstract] [Full Text] [Related]

  • 10. Trandolapril/verapamil combination in hypertensive diabetic patients.
    García Donaire JA, Ruilope LM.
    Vasc Health Risk Manag; 2007 Dec 04; 3(1):77-82. PubMed ID: 17583177
    [Abstract] [Full Text] [Related]

  • 11. The fixed combination of verapamil SR/trandolapril.
    Widimský J.
    Expert Opin Pharmacother; 2000 Mar 04; 1(3):515-35. PubMed ID: 11249535
    [Abstract] [Full Text] [Related]

  • 12. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
    Lambertucci L, Di Serio C, Castellani S, Torrini M, Lotti E, Cristofari C, Masotti G, Marchionni N, Ungar A.
    Transl Res; 2011 Jun 04; 157(6):348-56. PubMed ID: 21575919
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ.
    Blood Press Suppl; 2007 Mar 04; 1():6-9. PubMed ID: 17566313
    [Abstract] [Full Text] [Related]

  • 14. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R, García Robles R, Rodríguez Pérez JC, Gómez Pajuelo C, Moreno Carretero E, Grupo de estudio MICROTRAN.
    Nefrologia; 2001 Mar 04; 21(5):456-63. PubMed ID: 11795014
    [Abstract] [Full Text] [Related]

  • 15. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M.
    J Hypertens Suppl; 1997 Mar 04; 15(2):S27-33. PubMed ID: 9218195
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.
    Int J Clin Pharmacol Ther; 1998 Aug 04; 36(8):425-31. PubMed ID: 9726695
    [Abstract] [Full Text] [Related]

  • 17. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB, Curran MP, Perry CM.
    Drugs; 2002 Aug 04; 62(17):2539-67. PubMed ID: 12421112
    [Abstract] [Full Text] [Related]

  • 18. Fixed combination verapamil SR/trandolapril.
    Dooley M, Goa KL.
    Drugs; 1998 Nov 04; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
    [Abstract] [Full Text] [Related]

  • 19. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
    Nomura S, Inami N, Kimura Y, Omoto S, Shouzu A, Nishikawa M, Iwasaka T.
    J Hum Hypertens; 2007 Jan 04; 21(1):38-44. PubMed ID: 17051237
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
    Rosolová H, Cech F, Sefrna F.
    Vnitr Lek; 2002 Aug 04; 48(8):701-6. PubMed ID: 12425199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.